Researchers discover master regulator that drives majority of lymphoma
A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein. However, a research team, led by investigators at Weill Cornell ...
Cancer
May 13, 2013 |
5 / 5 (3) |
0
|
Scientists find genetic key to why some cancer patients don't respond to treatment
(Medical Xpress) -- Researchers from Newcastle University have identified a gene variation carried by 20% of the population which can significantly affect how patients with a rare type of blood cancer will respond to treatment.
Cancer
Jan 05, 2012 |
5 / 5 (2) |
0
New type of deadly lymphoma identified
An international research team has identified a new type of deadly intestinal lymphoma that is particularly common in Asia. The team, led by clinician-scientists from the SingHealth Academic Healthcare Cluster, also developed ...
Cancer
Apr 01, 2013 |
5 / 5 (2) |
0
New genetic mutations found for non-Hodgkin lymphoma
Scientists at the BC Cancer Agency in British Columbia, Canada and their U.S. collaborators have identified a number of new genetic mutations involved in non-Hodgkin lymphoma, or NHL.
Cancer
Jul 28, 2011 |
5 / 5 (1) |
0
Less intense chemotherapy more effective and less toxic for patients with advanced Hodgkin's lymphoma
A study published Online First by The Lancet has found that patients with advanced Hodgkin's lymphoma (a cancer affecting lymph tissue) can be treated more effectively with lower doses of chemotherapy. The study is by Dr ...
Cancer
Apr 03, 2012 |
5 / 5 (1) |
0
Study identifies trigger for alternate reproduction of HIV-related cancer virus
A research team led by Children's National Medical Center has identified a trigger that causes latent Kaposi's sarcoma-associated herpesvirus (KSHV) to rapidly replicate itself. KSHV causes Kaposi's sarcoma, primary effusion ...
Cancer
Apr 17, 2012 |
5 / 5 (1) |
0
|
Radiation ups event-free, not overall survival in ped Hodgkin's
(HealthDay) -- For children with Hodgkin's lymphoma who respond to chemotherapy, treatment with low-dose involved-field radiation therapy (IFRT) improves event-free survival (EFS), but has no significant impact ...
Cancer
May 31, 2012 |
5 / 5 (1) |
0
'Rediscovered' lymphoma drug helps double survival: study
(HealthDay) -- A drug first developed in East Germany in the 1960s has re-emerged as a potent "new" weapon against certain types of non-Hodgkin lymphomas, researchers report.
Cancer
Jun 04, 2012 |
5 / 5 (1) |
0
|
Mutations in JAK3 gene identified in subtype of lymphoma provide potential drug target
A substantial proportion of NK/T-cell lymphomas harbor Janus Kinase 3 gene mutations. Patients with these lymphomas might benefit from treatment with a Janus Kinase inhibitor according to a study published in Cancer Discovery, a jour ...
Cancer
Jun 15, 2012 |
5 / 5 (1) |
0
New drug dramatically improves survival in Hodgkin lymphoma patients
A new cancer drug with remarkably few side effects is dramatically improving survival in Hodgkin lymphoma patients who fail other treatments and are nearly out of options.
Cancer
Jun 27, 2012 |
5 / 5 (1) |
0
|
New research seeks to improve survival for myeloma and lymphoma patients
Researchers at the University of York are launching a major study of lymphoma and myeloma aimed at promoting earlier diagnosis and improving survival for patients with these cancers, which are among the most common in the ...
Cancer
Jul 25, 2012 |
5 / 5 (1) |
0
Watch-and-wait OK in low-tumor burden follicular lymphoma
(HealthDay)—An initial watch-and-wait strategy does not have a detrimental effect on the freedom from treatment failure (FFTF) or overall survival rate in selected patients with low-tumor burden follicular ...
Cancer
Sep 26, 2012 |
5 / 5 (1) |
0
Women respond better to the treatment of lymph gland cancer with antibodies than men
(Medical Xpress)—Women respond much better than men to the treatment of chronic follicular lymphoma with a monoclonal antibody that targets CD20 (rituximab). These are the findings of a multi-centre, Austria-wide ...
Cancer
Oct 10, 2012 |
5 / 5 (1) |
0
Genome sequencing of Burkitt Lymphoma reveals unique mutation
In the first broad genetic landscape mapped of a Burkitt lymphoma tumor, scientists at Duke Medicine and their collaborators identified 70 mutations, including several that had not previously been associated with cancer and ...
Genetics
Nov 12, 2012 |
5 / 5 (1) |
0
|
Small molecules in the blood might gauge radiation effects after exposure
Ohio State University cancer researchers have identified molecules in the bloodstream that might accurately gauge the likelihood of radiation illness after exposure to ionizing radiation.
Cancer
Feb 25, 2013 |
5 / 5 (1) |
0
|
